AcelRx Pharmaceuticals, Inc.

Redwood City,  CA 
United States
  • Booth: 1312

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings.  In November of 2018, its lead product candidate DSUVIA®  (sufentanil sublingual tablet 30 mcg) was approved by the U.S. Food and Drug Administration. 

Brands: Dsuvia Zalviso

Product Categories

For technical assistance with this webpage, please contact support